Sign Up to Receive the Latest Trading Tips and News from Prosper

    February 4, 2019

    Did Evolus Just Find the Fountain Of Youth?

    Evolus Inc (EOLS) shares are up sharply today after the company gained FDA approval for their flagship product, Jeuveau, a cosmetic injection used to reduce the appearance of wrinkles on the face. This means Jeuveau is a direct competitor to Botox, which of course is a big seller for its parent company, Allergan. Here’s a […]

    Read Article